Puengel et al. found that in nonalcoholic fatty liver disease (NAFLD), GPR84 expression was upregulated and correlated with the severity of inflammation and fibrosis (Puengel et al. 2020). The gene discussed is GPR84; the disease is metabolic dysfunction-associated steatotic liver disease.